AR008245A1 - Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados - Google Patents

Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados

Info

Publication number
AR008245A1
AR008245A1 ARP970102676A ARP970102676A AR008245A1 AR 008245 A1 AR008245 A1 AR 008245A1 AR P970102676 A ARP970102676 A AR P970102676A AR P970102676 A ARP970102676 A AR P970102676A AR 008245 A1 AR008245 A1 AR 008245A1
Authority
AR
Argentina
Prior art keywords
derivatives
prepare
manufacture
acetic acid
therapeutic agent
Prior art date
Application number
ARP970102676A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR008245A1 publication Critical patent/AR008245A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de la fórmula (I) o una sal, solvato o derivado del mismo funcional fisiológicamente, en el cual: X representa ya sea CH2-CCCH2 o CH=CH;Y representa un grupo de fórmula (II); R0 representa SO2Me o CONH2, y R1 es SO2Me, a procesos para su preparación, a composicones farmacéuticas quecontienen tales compuestos y a su uso en la preparación de agentes para el tratamiento de desórdenes trombóticos.
ARP970102676A 1996-06-21 1997-06-18 Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados AR008245A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds

Publications (1)

Publication Number Publication Date
AR008245A1 true AR008245A1 (es) 1999-12-29

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102676A AR008245A1 (es) 1996-06-21 1997-06-18 Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados

Country Status (17)

Country Link
EP (1) EP0912555A1 (es)
JP (1) JP2000512648A (es)
KR (1) KR20000022041A (es)
AP (1) AP9801417A0 (es)
AR (1) AR008245A1 (es)
AU (1) AU3261197A (es)
BR (1) BR9709930A (es)
CA (1) CA2258753A1 (es)
CZ (1) CZ424698A3 (es)
EA (1) EA199801015A1 (es)
ID (1) ID17052A (es)
IL (1) IL127464A0 (es)
IS (1) IS4924A (es)
NO (1) NO985974L (es)
PL (1) PL330797A1 (es)
TR (1) TR199802665T2 (es)
WO (1) WO1997049699A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
US7064215B2 (en) 2001-07-03 2006-06-20 Chiron Corporation Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
WO2004074243A2 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WO2007117413A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
CN101578265B (zh) 2007-01-10 2013-05-08 霍夫曼-拉罗奇有限公司 用作糜蛋白酶抑制剂的磺酰胺衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH07501063A (ja) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド フィブリノーゲン依存性血小板凝集阻害剤としてのピペリジン酢酸誘導体
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2000512648A (ja) 2000-09-26
IS4924A (is) 1998-12-15
ID17052A (id) 1997-12-04
CZ424698A3 (cs) 1999-05-12
CA2258753A1 (en) 1997-12-31
IL127464A0 (en) 1999-10-28
NO985974D0 (no) 1998-12-18
AU3261197A (en) 1998-01-14
EA199801015A1 (ru) 1999-08-26
AP9801417A0 (en) 1998-12-31
KR20000022041A (ko) 2000-04-25
EP0912555A1 (en) 1999-05-06
WO1997049699A1 (en) 1997-12-31
PL330797A1 (en) 1999-06-07
NO985974L (no) 1999-02-17
BR9709930A (pt) 1999-08-10
TR199802665T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
ES2145922T3 (es) Compuestos espiro-azabiciclicos utiles en terapia.
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
FI801769A (fi) Paromomycin-derivat foerfarande foer deras framstaellning och terapeutiska kompositioner daer de ingaor
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
ES471993A1 (es) Procedimiento de preparacion de nuevos derivados de alcaloi-des pentaciclicos
GT199900171A (es) Concentrado oral de sertralina.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
SE9900190D0 (sv) New compounds
AR005724A1 (es) Derivados de ureido biologicamente activos utiles en el tratamiento de esclerosis multiple
GB1505525A (en) Pyridopyrimidines
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer